Clinical Trials Listing Service

CMV (Cytomegalovirus) Vaccine

Last updated: January 16, 2023
Sponsor: Moderna
Overall Status: Active - Recruiting

Phase

3

Condition

Cytomegalovirus Infections

Vaccines

Women's Health

Treatment

N/A

Clinical Study ID

TX310305
  • Ages 16-40
  • Female

Study Summary

Let us be the generation who stands up to cytomegalovirus (CMV), a highly contagious viral infection that can harm an unborn child. CMV is a leading cause of birth defects around the world and is the number one infection that causes birth defects in the U.S. Currently, there is no approved vaccine against this devastating virus, CMVictory Trial is a clinical trial for an investigational vaccine to protect against CMV infection. Let's stand up to CMV.

Eligibility Criteria

Inclusion

Inclusion Criteria

  • A woman between 16-40 years of age
  • In good health
  • Not pregnant or planning on becoming pregnant within the next 9 months
  • In close contact with at least one child 5 years of age or younger for at least 8 hours a week, if age 20 or older

Study Design

Study Start date:
December 19, 2022
Estimated Completion Date:
October 31, 2023

Study Description

No cost to participate.

Compensation may be provided.

Patients should be within a 30 mile radius of the facility

Connect with a study center

  • ACRC TRIALS

    Frisco, Texas 75033
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.